Idarubicin Hydrochloride - CAS 57852-57-0
Catalog number: B0084-094874
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
Idarubicin HCl is a hydrochloride salt form of Idarubicin which is an anthracycline antibiotic and a DNA topoisomerase II (topo II) inhibitor for MCF-7 cells with IC50 of 3.3 ng/mL.
Publictions citing BOC Sciences Products
  • >> More
4-demethoxydaunorubicin (NSC256439, 4-DMDR) HCl
1.A comparative study of idarubicin 12 mg/m(2) and 8 mg/m(2) combined with cytarabine as the first induction regimen for adult acute myeloid leukemia patients.
Zhou L1, Liu X1, Liu H1, Zhu W1, Cai X1, Song K1, Zheng C1, Tang B1, Sun Z1. Onco Targets Ther. 2016 Feb 29;9:985-91. doi: 10.2147/OTT.S96176. eCollection 2016.
OBJECTIVE: This study aimed to explore a suitable dose of idarubicin (IDA) combined with cytarabine for the initial induction regimen for acute myeloid leukemia (AML) patients.
2.Identification of compounds that modulate retinol signaling using a cell-based qHTS assay.
Chen Y1, Sakamuru S2, Huang R2, Reese DH3, Xia M2. Toxicol In Vitro. 2016 Apr;32:287-96. doi: 10.1016/j.tiv.2016.01.011. Epub 2016 Jan 25.
In vertebrates, the retinol (vitamin A) signaling pathway (RSP) controls the biosynthesis and catabolism of all-trans retinoic acid (atRA), which regulates transcription of genes essential for embryonic development. Chemicals that interfere with the RSP to cause abnormal intracellular levels of atRA are potential developmental toxicants. To assess chemicals for the ability to interfere with retinol signaling, we have developed a cell-based RARE (Retinoic Acid Response Element) reporter gene assay to identify RSP disruptors. To validate this assay in a quantitative high-throughput screening (qHTS) platform, we screened the Library of Pharmacologically Active Compounds (LOPAC) in both agonist and antagonist modes. The screens detected known RSP agonists, demonstrating assay reliability, and also identified novel RSP agonists including kenpaullone, niclosamide, PD98059 and SU4312, and RSP antagonists including Bay 11-7085, LY294002, 3,4-Methylenedioxy-β-nitrostyrene, and topoisomerase inhibitors (camptothecin, topotecan, amsacrine hydrochloride, and idarubicin).
3.Pentoxifylline affects idarubicin binding to DNA.
Gołuński G1, Borowik A1, Lipińska A2, Romanik M1, Derewońko N2, Woziwodzka A1, Piosik J3. Bioorg Chem. 2016 Apr;65:118-25. doi: 10.1016/j.bioorg.2016.02.005. Epub 2016 Feb 20.
Anticancer drug idarubicin - derivative of doxorubicin - is commonly used in treatment of numerous cancer types. However, in contrast to doxorubicin, its biophysical properties are not well established yet. Additionally, potential direct interactions of idarubicin with other biologically active aromatic compounds, such as pentoxifylline - representative of methylxanthines - were not studied at all. Potential formation of such hetero-aggregates may result in sequestration of the anticancer drug and, in consequence, reduction of its biological activity. This work provide description of the idarubicin biophysical properties as well as assess influence of pentoxifylline on idarubicin interactions with DNA. To achieve these goals we employed spectrophotometric methods coupled with analysis with the appropriate mathematical models as well as flow cytometry and Ames test. Obtained results show influence of pentoxifylline on idarubicin binding to DNA and are well in agreement with the data previously published for other aromatic ligands.
4.Clofarabine Plus Low-Dose Cytarabine Is as Effective as and Less Toxic Than Intensive Chemotherapy in Elderly AML Patients.
Takahashi K1, Kantarjian H2, Garcia-Manero G2, Borthakur G2, Kadia T2, DiNardo C2, Jabbour E2, Pierce S2, Estrov Z2, Konopleva M2, Andreeff M2, Ravandi F2, Cortes J3. Clin Lymphoma Myeloma Leuk. 2016 Mar;16(3):163-168.e2. doi: 10.1016/j.clml.2015.11.016. Epub 2015 Nov 24.
INTRODUCTION: Most patients with acute myeloid leukemia (AML) age ≥ 60 years are not offered intensive induction because of high mortality. Phase 2 studies of clofarabine plus low-dose cytarabine (CLDA) as frontline therapy for elderly AML patients demonstrated high response and acceptable toxicity.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Topoisomerase Products

ABT-719 HCl
(CAS: 162763-53-3)

The hydrochloride salt form of ABT-719, a fluoroquinolone derivative, has been found to be a DNA topoisomerase inhibitor that was once developed in antibacteria...

Elomotecan HCl salt
(CAS: 220997-99-9)

Elomotecan, also referred to BN 80927 and R 1559, characterized by a stable seven-membered beta-hydroxylactone ring, is a DNA topoisomerase inhibitor. In vivo e...

CAS 57576-44-0 Aclarubicin

(CAS: 57576-44-0)

Aclarubicin is an oligosaccharide anthracycline antineoplastic antibiotic isolated from the bacterium Streptomyces galilaeus. It intercalates into DNA and inter...

CAS 33419-42-0 Etoposide

(CAS: 33419-42-0)

Etoposide is a semisynthetic derivative of podophyllotoxin, which inhibits DNA synthesis via topoisomerase II inhibition activity.

CAS 119413-54-6 Topotecan Hydrochloride

Topotecan Hydrochloride
(CAS: 119413-54-6)

Topocecan is a semisynthetic derivative of camptothecin with antineoplastic activity. During the S phase of the cell cycle, topotecan selectively stabilizes top...

CAS 446-72-0 Genistein

(CAS: 446-72-0)

Genistein, a phytoestrogen found in soy products, is a highly specific inhibitor of protein tyrosine kinase (PTK) which blocks the mitogenic effect mediated by ...

CAS 211100-13-9 Sabarubicin

(CAS: 211100-13-9)

Sabarubicina, a disaccharide analogue of doxorubicin, is an antineoplastic agent which can intercalate into the DNA of tumor cells and interact with topoisomera...

CAS 78186-34-2 Bisantrene Dihydrochloride

Bisantrene Dihydrochloride
(CAS: 78186-34-2)

Bisantrene Dihydrochloride is the hydrochloride salt of Bisantrene. Bisantrene, also referred to CL-216942, Cyabin or NSC-337766, an anthracene bishydrazone der...

CAS 29767-20-2 Teniposide

(CAS: 29767-20-2)

Teniposide is a chemotherapeutic medication mainly used in the treatment of childhood acute lymphocytic leukemia (ALL).It is in a class of drugs known as podoph...

CAS 867063-97-6 Atiratecan

(CAS: 867063-97-6)

Atiratecan is a topoisomerase inhibitor. It has potential anticancer activity.

CAS 1562066-98-1 Banoxantrone D12 dihydrochloride

Banoxantrone D12 dihydrochloride
(CAS: 1562066-98-1)

The deuterium labeled banoxantrone dihydrochloride. Banoxantrone is a potent topoisomerase II inhibitor.

Alatrofloxacin Mesylate
(CAS: 157605-25-9)

The mesylate salt form of alatrofloxacin, a fluoroquinolone derivative, has been found to be a Type II DNA topoisomerase inhibitor that was once developed to be...

CAS 110311-30-3 Amrubicin hydrochloride

Amrubicin hydrochloride
(CAS: 110311-30-3)

Amrubicin hydrochloride is a topoisomerase II inhibitor used in the treatment of lung cancer.

CAS 252979-56-9 Banoxantrone dihydrochloride

Banoxantrone dihydrochloride
(CAS: 252979-56-9)

Banoxantrone dihydrochloride, a bioreductive prodrug, can be reduced to a stable, DNA-affinic compound AQ4, which is a potent topoisomerase II inhibitor, and ex...

CAS 151271-53-3 UK-1

(CAS: 151271-53-3)

UK-1, a benzoxazol derivative, has been found to a Streptomyces metabolite that could exhibit anticancer activity and topoisomerase II restraination activity.

CAS 529488-28-6 GENZ-644282

(CAS: 529488-28-6)

Genz-644282 is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibi...

CAS 169869-90-3 Exatecan mesylate

Exatecan mesylate
(CAS: 169869-90-3)

Exatecan mesylate is a semisynthetic, water-soluble derivative of camptothecin with antineoplastic activity. Exatecan mesylate inhibits topoisomerase I activity...

CAS 72496-41-4 Pirarubicin

(CAS: 72496-41-4)

Pirarubicin is an anthracycline antibiotic, and also a DNA/RNA synthesis inhibitor by intercalating into DNA and interacts with topoisomerase II, used as an ant...

CAS 174634-08-3 TAS-103

(CAS: 174634-08-3)

TAS-103, also known as BMS-247615, is a quinoline derivative that displays antitumor activity in murine and human tumor models. TAS-103 has been reported to be ...

CAS 56390-09-1 Epirubicin Hydrochloride

Epirubicin Hydrochloride
(CAS: 56390-09-1)

Epirubicin HCl, a semisynthetic L-arabino derivative of doxorubicin, is an antineoplastic agent by inhibiting Topoisomerase.

Chemical Structure

CAS 57852-57-0 Idarubicin Hydrochloride

Quick Inquiry

Verification code

Featured Items